8-K: Xcel Brands Secures $15M Equity Line with White Lion Capital

Xcel Brands, Inc. has entered into a common stock purchase agreement with White Lion Capital, LLC for up to $15.0 million in equity financing over two years, alongside a registration rights agreement.

Summary

• Secured a common stock purchase agreement with White Lion Capital, LLC for up to $15.0 million in equity financing.
• The agreement grants the company the right, but not the obligation, to sell common stock to White Lion Capital, LLC at its discretion over a 24-month period.
• Purchase prices for shares will be based on market prices, specifically the average of the three lowest closing prices for Regular Purchases, the average of the two lowest traded prices for Rapid Purchases, and 97% of the lowest daily Volume Weighted Average Price (VWAP) for VWAP Purchases.
• The company will issue $37,500 worth of common stock to White Lion Capital, LLC as a commitment fee, which is fully earned and non-refundable.
• Proceeds from sales are intended for working capital and general corporate purposes.
• The company is obligated to file a registration statement (Form S-1 or S-3) within 60 days of the Execution Date (January 21, 2026) to allow White Lion Capital, LLC to resell the purchased shares.
• Sales are subject to limitations, including an Exchange Cap of 1,178,173 shares (19.99% of outstanding common stock) unless stockholder approval is obtained or the average price paid equals or exceeds $1.36.
• A 4.0% cash fee on gross proceeds received from sales to the Investor will be paid to Maxim Group LLC.

Sentiment

Score: 6

Explanation: The agreement provides a flexible source of capital for Xcel Brands, which is a positive for liquidity and operational funding. However, the potential for dilution, market-based pricing that could be unfavorable, and associated fees introduce some negative aspects. It's a standard financing tool, neither exceptionally good nor bad, but provides necessary financial flexibility.

Positives

• Secures up to $15.0 million in potential equity financing, providing a flexible funding source for working capital and general corporate purposes.
• The company retains discretion over the timing and amount of share sales, allowing it to manage dilution and market impact.
• The investor is prohibited from engaging in short sales of the common stock during the agreement term, which could help stabilize the stock price.
• The company can terminate the agreement at any time upon written notice without cost or penalty, offering flexibility.

Negatives

• The pricing mechanisms (average of lowest prices, VWAP with a discount) could lead to sales at potentially lower prices, increasing dilution for existing shareholders.
• The issuance of $37,500 in commitment shares to the investor represents immediate dilution and a cost for entering the agreement.
• The 4.0% cash fee to Maxim Group LLC on gross proceeds further reduces the net capital raised.
• The Exchange Cap (19.99% of outstanding shares or 1,178,173 shares) may require stockholder approval for the company to fully utilize the $15.0 million commitment, potentially limiting the capital available without further action.
• The agreement restricts the company from entering into other 'equity line or substantially similar transactions' during the commitment period, limiting future financing options of that specific type.

Risks

• **Dilution Risk:** The sale of common stock to the investor will dilute the ownership interest of existing shareholders, especially if shares are sold at lower market prices.
• **Market Price Volatility:** The actual amount of proceeds received will depend on the trading price of the common stock, which can be volatile.
• **Regulatory Compliance:** Failure to obtain stockholder approval for sales exceeding the Exchange Cap could limit the company's ability to raise the full $15.0 million.
• **Registration Statement Effectiveness:** The investor's obligation to purchase shares is contingent on the registration statement remaining effective, and any suspension or withdrawal could halt sales.
• **Beneficial Ownership Limitation:** The investor's beneficial ownership limit of 4.99% (or 9.99% with notice) could restrict the volume of shares purchased at any given time.
• **Operational Funding:** The company's assessment of appropriate funding sources for its operations will influence the timing and amount of sales, introducing uncertainty.

Future Outlook

The company intends to use any proceeds from the equity line for working capital and general corporate purposes. The actual amount and timing of sales will depend on market conditions, the trading price of the common stock, and the company's assessment of appropriate funding sources.

Management Comments

• The company currently intends to use any proceeds from such sales for working capital and general corporate purposes.

Industry Context

na

Corporate Governance

Stakeholder Impact

• **Shareholders:** Potential for dilution from the issuance of new common stock, especially if shares are sold at lower market prices. The Exchange Cap provides some protection against immediate significant dilution without approval.
• **Company Operations:** Provides a flexible source of capital for working capital and general corporate purposes, supporting ongoing operations and strategic initiatives.
• **Creditors:** Improved liquidity from the capital raise could enhance the company's ability to meet its financial obligations.

Next Steps

• The company will file a Current Report on Form 8-K, including the Transaction Documents as exhibits.
• The company will file a registration statement on Form S-1 or S-3 within 60 days of the Execution Date (by March 22, 2026) to register the resale of the Registrable Securities by the Investor.
• The company will use commercially reasonable best efforts to have the registration statement declared effective and keep it effective during the Registration Period.
• The company may, at its discretion, issue Purchase Notice Shares to the Investor over the 24-month Commitment Period.
• The company will issue $37,500 in Commitment Shares to the Investor.
• The company will pay Maxim Group LLC a 4.0% cash fee on gross proceeds from sales.
• The company may seek stockholder approval to issue shares in excess of the Exchange Cap if necessary.

Key Dates

Recommendation

The equity line provides Xcel Brands with a flexible capital source for working capital and general corporate purposes, which is a positive for liquidity. However, the potential for dilution from market-priced share sales and associated fees introduces a cautionary element. The agreement is a standard financing mechanism, not indicating a significant change in the company's fundamental outlook, but rather a means to manage ongoing funding needs. Investors should monitor the actual utilization of the equity line and the prices at which shares are sold, as well as the company's operational performance, before making significant investment changes.

Keywords

Xcel Brands, XELB, White Lion Capital, Equity Financing, Common Stock, Capital Raise, Dilution, SEC Filing, Form 8-K, Registration Rights Agreement, Working Capital, Corporate Purposes, Investment Agreement, Stock Purchase, Nasdaq Capital Market